An observational study in Diabetic Retinopathy and Type2 Diabetes, sponsored by Aalborg University. Completed at 1 site in Denmark. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-05-06.
Sponsored by Aalborg University · Observational
Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.
The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.
815 studies on the registry are indexed under Retinal Diseases; 105 are open to participants now.
This study's enrollment of 300 is above the median of 180 across 282 observational studies indexed under Retinal Diseases.
Browse Retinal Diseases studies →Aalborg University is the lead sponsor of 178 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population is patients diagnosed with type 2 diabetes treated in general practice within the Region of North Jutland. We are excluding patients above the age of 70 as patients at this age diagnosed with diabetes have a higher risk of developing other eye diseases, such as glaucoma or cataracts, so the general practitioners would still have to advice this patient group to schedule consultations at an ophthalmologist even though they have no sign of retinopathy.
Patients who participate in the project must fulfill all inclusion criteria and cannot fulfill any exclusion criteria listed below.
Exclusion Criteria:
People diagnosed with type 2 diabetes age 18-70
Diagnostic Test: Diabetic Retinopathy Screening
Screenings are performed in the diabetes consultation in general practice
Patients' acceptance of diabetic retinopathy screenings in general practice
Questionnaire
Time frame: 1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aalborg University